BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 32469207)

  • 1. Identifying Risk Factors for Levels of Per- and Polyfluoroalkyl Substances (PFAS) in the Placenta in a High-Risk Pregnancy Cohort in North Carolina.
    Bangma J; Eaves LA; Oldenburg K; Reiner JL; Manuck T; Fry RC
    Environ Sci Technol; 2020 Jul; 54(13):8158-8166. PubMed ID: 32469207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of per- and polyfluoroalkyl substances (PFAS) in human placental tissues and associations with birth outcomes.
    Hall SM; Zhang S; Hoffman K; Miranda ML; Stapleton HM
    Chemosphere; 2022 May; 295():133873. PubMed ID: 35143854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentrations of perfluoroalkyl substances (PFASs) in human embryonic and fetal organs from first, second, and third trimester pregnancies.
    Mamsen LS; Björvang RD; Mucs D; Vinnars MT; Papadogiannakis N; Lindh CH; Andersen CY; Damdimopoulou P
    Environ Int; 2019 Mar; 124():482-492. PubMed ID: 30684806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis and distribution of per- and polyfluoroalkyl substances in decidua and villi placenta explants.
    Pascali JP; Piva E; Bonasoni MP; Migliavacca C; Seidenari A; Fais P
    Environ Res; 2023 Jul; 229():115955. PubMed ID: 37119845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prenatal exposure to perfluoroalkyl substances and birth outcomes in a Spanish birth cohort.
    Manzano-Salgado CB; Casas M; Lopez-Espinosa MJ; Ballester F; Iñiguez C; Martinez D; Costa O; Santa-Marina L; Pereda-Pereda E; Schettgen T; Sunyer J; Vrijheid M
    Environ Int; 2017 Nov; 108():278-284. PubMed ID: 28917208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perfluoroalkyl Substances during Pregnancy and Offspring Weight and Adiposity at Birth: Examining Mediation by Maternal Fasting Glucose in the Healthy Start Study.
    Starling AP; Adgate JL; Hamman RF; Kechris K; Calafat AM; Ye X; Dabelea D
    Environ Health Perspect; 2017 Jun; 125(6):067016. PubMed ID: 28669937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considering environmental exposures to per- and polyfluoroalkyl substances (PFAS) as risk factors for hypertensive disorders of pregnancy.
    Erinc A; Davis MB; Padmanabhan V; Langen E; Goodrich JM
    Environ Res; 2021 Jun; 197():111113. PubMed ID: 33823190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early life exposure to per- and polyfluoroalkyl substances (PFAS) and latent health outcomes: A review including the placenta as a target tissue and possible driver of peri- and postnatal effects.
    Blake BE; Fenton SE
    Toxicology; 2020 Oct; 443():152565. PubMed ID: 32861749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating maternal exposure to an environmental per and polyfluoroalkyl substances (PFAS) mixture during pregnancy: Adverse maternal and fetoplacental effects in a New Zealand White (NZW) rabbit model.
    Crute CE; Hall SM; Landon CD; Garner A; Everitt JI; Zhang S; Blake B; Olofsson D; Chen H; Murphy SK; Stapleton HM; Feng L
    Sci Total Environ; 2022 Sep; 838(Pt 4):156499. PubMed ID: 35679923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PFAS concentration during pregnancy in relation to cardiometabolic health and birth outcomes.
    Gardener H; Sun Q; Grandjean P
    Environ Res; 2021 Jan; 192():110287. PubMed ID: 33038367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profiles and transplacental transfer of per- and polyfluoroalkyl substances in maternal and umbilical cord blood: A birth cohort study in Zhoushan, Zhejiang Province, China.
    Liu L; Yan P; Liu X; Zhao J; Tian M; Huang Q; Yan J; Tong Z; Zhang Y; Zhang J; Zhang T; Guo J; Liu G; Bian X; Li B; Wang T; Wang H; Shen H
    J Hazard Mater; 2024 Mar; 466():133501. PubMed ID: 38246060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of linear and branched perfluoroalkane sulfonic acids (PFSAs) in women and infants during pregnancy and lactation.
    Varsi K; Huber S; Averina M; Brox J; Bjørke-Monsen AL
    Environ Int; 2022 Feb; 160():107065. PubMed ID: 34959199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of paternal and maternal per- and polyfluoroalkyl substances exposure with cord serum reproductive hormones, placental steroidogenic enzyme and birth weight.
    Yao Q; Gao Y; Zhang Y; Qin K; Liew Z; Tian Y
    Chemosphere; 2021 Dec; 285():131521. PubMed ID: 34273704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations between prenatal maternal exposure to per- and polyfluoroalkyl substances (PFAS) and polybrominated diphenyl ethers (PBDEs) and birth outcomes among pregnant women in San Francisco.
    Eick SM; Hom Thepaksorn EK; Izano MA; Cushing LJ; Wang Y; Smith SC; Gao S; Park JS; Padula AM; DeMicco E; Valeri L; Woodruff TJ; Morello-Frosch R
    Environ Health; 2020 Sep; 19(1):100. PubMed ID: 32938446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetal Glucocorticoid Mediates the Association between Prenatal Per- and Polyfluoroalkyl Substance Exposure and Neonatal Growth Index: Evidence from a Birth Cohort Study.
    Cai D; Li QQ; Mohammed Z; Chou WC; Huang J; Kong M; Xie Y; Yu Y; Hu G; Qi J; Zhou Y; Tan W; Lin L; Qiu R; Dong G; Zeng XW
    Environ Sci Technol; 2023 Aug; 57(31):11420-11429. PubMed ID: 37494580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prenatal exposure to 11 perfluoroalkyl substances and fetal growth: A large-scale, prospective birth cohort study.
    Kashino I; Sasaki S; Okada E; Matsuura H; Goudarzi H; Miyashita C; Okada E; Ito YM; Araki A; Kishi R
    Environ Int; 2020 Mar; 136():105355. PubMed ID: 32029284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal trajectories and determinants of plasma per- and polyfluoroalkyl substance (PFAS) levels from birth to early childhood and metabolomic associations: A pilot study in the Boston Birth Cohort.
    Zhang M; Yu CH; Wang G; Buckley JP; Hong X; Pearson C; Adams WG; Fan ZT; Wang X
    Precis Nutr; 2022 Jun; 1(1):. PubMed ID: 36936201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of plasma concentrations of perfluoroalkyl and polyfluoroalkyl substances in pregnant women from a birth cohort in Shanghai, China.
    Tian Y; Zhou Y; Miao M; Wang Z; Yuan W; Liu X; Wang X; Wang Z; Wen S; Liang H
    Environ Int; 2018 Oct; 119():165-173. PubMed ID: 29958117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early-Life Exposure to Per- and Poly-Fluorinated Alkyl Substances and Growth, Adiposity, and Puberty in Children: A Systematic Review.
    Lee YJ; Jung HW; Kim HY; Choi YJ; Lee YA
    Front Endocrinol (Lausanne); 2021; 12():683297. PubMed ID: 34566884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal exposure to per- and polyfluoroalkyl substances, fetal thyroid hormones, and infant neurodevelopment.
    Yao Q; Vinturache A; Lei X; Wang Z; Pan C; Shi R; Yuan T; Gao Y; Tian Y
    Environ Res; 2022 Apr; 206():112561. PubMed ID: 34954147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.